Reported covered position: OFFICE OF U.S. SENATOR JOHN GLENN
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FAIR Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885 / S. 3989)
FAIR Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026. Applies prior auth reforms to Part D, CHIP, Medicaid. Not introduced in the 2nd Quarter Support the Fair Access in Residency (FAIR) Act (H.R. 2314 and S. 2715) to require equal recognition of the Comprehensive Osteopathic Medical Licensing Exam (COMLEX) Support the Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via SUMMIT HEALTH CARE CONSULTING
2026 · second_quarter · 2A
Medicare physician payment reform (no specific legislation)
Support Dillon's Law (H.R. 4564)
Filing targets: HOUSE OF REPRESENTATIVES
Source: Senate LDA
| AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS, INC | 17 | 2022–2026 |
| NEVADA CANCER INSTITUTE | 14 | 2007–2011 |
| SANOFI-AVENTIS U.S. INC. | 14 | 2008–2011 |
| FIGHT COLORECTAL CANCER | 12 | 2011–2014 |
| THE SOCIETY OF THORACIC SURGEONS | 9 | 2008–2010 |
| AMERICAN SOCIETY FOR MICROBIOLOGY | 7 | 2018–2019 |
| AMERICAN SOCIETY OF RETINA SPECIALISTS | 5 | 2014–2015 |
| AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 4 | 2008 |
| AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS | 3 | 2026 |
| MCKESSON SPECIALTY HEALTH | 2 | 2014–2015 |
| BAXTER HEALTHCARE CORPORATION | 1 | 2026 |
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose Centers for Medicare and Medicaid Services' (CMS) proposal to implement an efficiency adjustment to Medicare Physician Fee Schedule payments. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Oppose the CMS practice expense site differential proposal (no specific legislation) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support reform of the Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule (no specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes Support the Ensuring Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026 which reforms prior authorization processes and applies to Part D, CHIP, Medicaid. No specific legislation introduced in second quarter.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026. Applies prior auth reforms to Part D, CHIP, Medicaid. Not introduced in the 2nd Quarter Support the Fair Access in Residency (FAIR) Act (H.R. 2314 and S. 2715) to require equal recognition of the Comprehensive Osteopathic Medical Licensing Exam (COMLEX) Support the Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816)
Community TEAMS Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885 / S. 3989)
Community TEAMS Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Community TEAMS Act (H.R. 3885 / S. 3989) Support Dillon's Law (H.R. 4564)
Dillon’s Law
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: SUMMIT HEALTH CARE CONSULTING
Support Dillon's Law (H.R. 4564)
Dillon’s Law
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Community TEAMS Act (H.R. 3885 / S. 3989) Support Dillon's Law (H.R. 4564)
Resident Physician Shortage Reduction Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Resident Physician Shortage Reduction Act (H.R. 4731 / S. 2439)
Resident Physician Shortage Reduction Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Support the Resident Physician Shortage Reduction Act (H.R. 4731 / S. 2439)
Patients Deserve Price Tags Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose the Patients Deserve Price Tags Act (S. 2355 / H.R. 5582). The bill requires price transparency, including discounted cash price and payer-specific negotiated rates, from all imaging providers, including physician practices. Support the he H-1Bs for Physicians and the Healthcare Workforce Act (H.R. 7961), which would exempt healthcare professionals from the $100,000 H-1B petition fee
Medical Foods and Formulas Access Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Medical Foods and Formulas Access Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Pediatric indications for biologic products to treat inflammatory bowel disease
ROOT Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule Support the Provider Reimbursement Stability Act (H.R. 8163), which would reform outdated physician fee schedule budget-neutrality requirements, including raising the existing $20 million budget-neutrality trigger to $54.3 million. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would pause the new Medicare -2.5% efficiency adjustment and require CMS to issue a report with data justifying a one-time efficiency adjustment application and only if certain conditions are met. Oppose the Radiology Outpatient Ordering Transmission (ROOT) Act (S. 1692 / H.R. 5737) which requires the consultation of appropriate use criteria for advanced diagnostic imaging in the Medicare program
Efficiency Adjustment Delay Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose Centers for Medicare and Medicaid Services' (CMS) proposal to implement an efficiency adjustment to Medicare Physician Fee Schedule payments. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Oppose the CMS practice expense site differential proposal (no specific legislation) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes
Efficiency Adjustment Delay Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030.
Efficiency Adjustment Delay Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule Support the Provider Reimbursement Stability Act (H.R. 8163), which would reform outdated physician fee schedule budget-neutrality requirements, including raising the existing $20 million budget-neutrality trigger to $54.3 million. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would pause the new Medicare -2.5% efficiency adjustment and require CMS to issue a report with data justifying a one-time efficiency adjustment application and only if certain conditions are met. Oppose the Radiology Outpatient Ordering Transmission (ROOT) Act (S. 1692 / H.R. 5737) which requires the consultation of appropriate use criteria for advanced diagnostic imaging in the Medicare program
Efficiency Adjustment Delay Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Support the Resident Physician Shortage Reduction Act (H.R. 4731 / S. 2439)
H–1Bs for Physicians and the Healthcare Workforce Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose the Patients Deserve Price Tags Act (S. 2355 / H.R. 5582). The bill requires price transparency, including discounted cash price and payer-specific negotiated rates, from all imaging providers, including physician practices. Support the he H-1Bs for Physicians and the Healthcare Workforce Act (H.R. 7961), which would exempt healthcare professionals from the $100,000 H-1B petition fee
Provider Reimbursement Stability Act of 2026
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule Support the Provider Reimbursement Stability Act (H.R. 8163), which would reform outdated physician fee schedule budget-neutrality requirements, including raising the existing $20 million budget-neutrality trigger to $54.3 million. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would pause the new Medicare -2.5% efficiency adjustment and require CMS to issue a report with data justifying a one-time efficiency adjustment application and only if certain conditions are met. Oppose the Radiology Outpatient Ordering Transmission (ROOT) Act (S. 1692 / H.R. 5737) which requires the consultation of appropriate use criteria for advanced diagnostic imaging in the Medicare program
Prior Authorization Reform for Autoimmune and Blood Disorders Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192), which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Prior Authorization Reform for Autoimmune and Blood Disorders Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose the Patients Deserve Price Tags Act (S. 2355), specifically Section 5. Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Prior Authorization Reform for Autoimmune and Blood Disorders Act
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule Support the Provider Reimbursement Stability Act (H.R. 8163), which would reform outdated physician fee schedule budget-neutrality requirements, including raising the existing $20 million budget-neutrality trigger to $54.3 million. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would pause the new Medicare -2.5% efficiency adjustment and require CMS to issue a report with data justifying a one-time efficiency adjustment application and only if certain conditions are met. Oppose the Radiology Outpatient Ordering Transmission (ROOT) Act (S. 1692 / H.R. 5737) which requires the consultation of appropriate use criteria for advanced diagnostic imaging in the Medicare program
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026. Applies prior auth reforms to Part D, CHIP, Medicaid. Not introduced in the 2nd Quarter Support the Fair Access in Residency (FAIR) Act (H.R. 2314 and S. 2715) to require equal recognition of the Comprehensive Osteopathic Medical Licensing Exam (COMLEX) Support the Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816)
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support reform of the Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule (no specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes Support the Ensuring Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026 which reforms prior authorization processes and applies to Part D, CHIP, Medicaid. No specific legislation introduced in second quarter.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose Centers for Medicare and Medicaid Services' (CMS) proposal to implement an efficiency adjustment to Medicare Physician Fee Schedule payments. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Oppose the CMS practice expense site differential proposal (no specific legislation) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes
Patients Deserve Price Tags Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose the Patients Deserve Price Tags Act (S. 2355), specifically Section 5. Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Patients Deserve Price Tags Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose the Patients Deserve Price Tags Act (S. 2355 / H.R. 5582). The bill requires price transparency, including discounted cash price and payer-specific negotiated rates, from all imaging providers, including physician practices. Support the he H-1Bs for Physicians and the Healthcare Workforce Act (H.R. 7961), which would exempt healthcare professionals from the $100,000 H-1B petition fee
Patients Deserve Price Tags Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Oppose the Patients Deserve Price Tags Act (S. 2355), specifically Section 5.
Resident Physician Shortage Reduction Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Resident Physician Shortage Reduction Act (H.R. 4731 / S. 2439)
Resident Physician Shortage Reduction Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Support the Resident Physician Shortage Reduction Act (H.R. 4731 / S. 2439)
FAIR Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885 / S. 3989)
FAIR Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026. Applies prior auth reforms to Part D, CHIP, Medicaid. Not introduced in the 2nd Quarter Support the Fair Access in Residency (FAIR) Act (H.R. 2314 and S. 2715) to require equal recognition of the Comprehensive Osteopathic Medical Licensing Exam (COMLEX) Support the Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816)
Medical Foods and Formulas Access Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Medical Foods and Formulas Access Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Pediatric indications for biologic products to treat inflammatory bowel disease
Community TEAMS Act of 2026
Client: AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Community TEAMS Act (H.R. 3885 / S. 3989) Support Dillon's Law (H.R. 4564)
Community TEAMS Act of 2026
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885 / S. 3989)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for those with gastrointestinal and metabolic disorders (no specific legislation) Oppose policies to the Children's Health Insurance Program and Medicaid that would lead to loss of coverage and access to care (H.R. 1)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879) Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Oppose S.1692 - Radiology Outpatient Ordering Transmission (ROOT) Act which would re-establish the Medicare Appropriate Use Criteria program for advanced diagnostic imaging
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
FAIR Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314)
FAIR Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (H.R. 2314) to facilitate training of osteopathic medical students
FAIR Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (H.R. 2314) to facilitate training of osteopathic medical students
FAIR Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885)
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514)
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879) Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Oppose S.1692 - Radiology Outpatient Ordering Transmission (ROOT) Act which would re-establish the Medicare Appropriate Use Criteria program for advanced diagnostic imaging
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Community TEAMS Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885)
Medical Foods and Formulas Access Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Medical Foods and Formulas Access Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684) Support the Cure Hepatitis C Act (S. 1941) Support Colorados Medicaid State Plan Amendment to allow dispensing fees for the preparation and dispensing of parenteral nutrition as approved by the Colorado General Assembly and signed into law [SB 25-084].
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879) Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Oppose S.1692 - Radiology Outpatient Ordering Transmission (ROOT) Act which would re-establish the Medicare Appropriate Use Criteria program for advanced diagnostic imaging
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 Impose restrictions on prior authorization practices used by Medicare Advantage plans (No specific legislation) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Prevent cut to Medicare physician payment, Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Prevent cut to Medicare physician payments, Medicare Patient Access and Practice Stabilization Act of 2025 (HR 879)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879) Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Oppose S.1692 - Radiology Outpatient Ordering Transmission (ROOT) Act which would re-establish the Medicare Appropriate Use Criteria program for advanced diagnostic imaging
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514)
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879) Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Oppose S.1692 - Radiology Outpatient Ordering Transmission (ROOT) Act which would re-establish the Medicare Appropriate Use Criteria program for advanced diagnostic imaging
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879) Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Oppose S.1692 - Radiology Outpatient Ordering Transmission (ROOT) Act which would re-establish the Medicare Appropriate Use Criteria program for advanced diagnostic imaging
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514)
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Cure Hepatitis C Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Cure Hepatitis C Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684) Support the Cure Hepatitis C Act (S. 1941) Support Colorados Medicaid State Plan Amendment to allow dispensing fees for the preparation and dispensing of parenteral nutrition as approved by the Colorado General Assembly and signed into law [SB 25-084].
FAIR Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885)
FAIR Act of 2025
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314)
Medical Foods and Formulas Access Act of 2025
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans (H.R. 8702 / S. 4518) Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation Improving patient access to biosimilars by closing the gap between the reimbursement rates and physician practice acquisition costs (no specific legislation)
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans (H.R. 8702 / S. 4518) Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans. No specific legislation 1st Quarter 2024 Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation Support the Colorectal Cancer Payment Fairness Act (H.R. 3382) to accelerate the timeline for removal of cost sharing among Medicare beneficiaries when a preventive screening colonoscopy involves the removal of polyps.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 4rd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support generally mitigating or stopping impending cut to the Medicare physician fee schedule conversion factor for CY2025. Support the Improving Seniors Timely Access to Care Act (H.R. 8702/S. 4532)
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Strengthening Medicare for Patients and Providers Act, (H.R. 2474), which provides a permanent annual update equal to the increase in the MEI, and the Provider Reimbursement Stability Act (H.R. 6371), which would reform budget neutrality requirements. Generally support elimination or reduction in scheduled Medicare physician fee schedule conversion factor for CY205. Support repeal of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. No specific legislation Support the the Improving Seniors Timely Access to Care Act (H.R. 8702/S. 4532)
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Strengthening Medicare for Patients and Providers Act, (H.R. 2474), which provides a permanent annual update equal to the increase in the MEI, and the Provider Reimbursement Stability Act (H.R. 6371), which would make much-needed reforms to budget neutrality. ASNC requests that passage of both bills be considered a priority. Support repeal of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. No specific legislation
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Strengthening Medicare for Patients and Providers Act, (H.R. 2474), which provides a permanent annual update equal to the increase in the MEI, and the Provider Reimbursement Stability Act (H.R. 6371), which would reform budget neutrality requirements. Generally support elimination or reduction in scheduled Medicare physician fee schedule conversion factor for CY205. Support repeal of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. No specific legislation
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 3rd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support generally mitigating or stopping impending cut to the Medicare physician fee schedule conversion factor for CY2025.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans (H.R. 8702 / S. 4518) Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 2nd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support the Rural Physician Workforce Preservation Act (H.R. 8235) to ensure that geographically rural hospitals receive the GME funding prioritization according to Section 126 of the Consolidated Appropriations Act of 2021.
Safe Step Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630)
Safe Step Act
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products. Oppose Biosimilar Red Tape Elimination Act (S. 2305) Improve pediatric indications for biologics (no specific legislation)
Safe Step Act
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Safe Step Act
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Safe Step Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630)
Safe Step Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630)
Safe Step Act
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Safe Step Act to provide protections against step therapy protocols (S. 652, H.R. 2630)
Safe Step Act
Client: NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products.
Safe Step Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Express concern with Sec. 104 (Ambulatory Surgical Center Price Transparency) of H.R. 5378 of the Lower Costs, More Transparency Act" and oppose Section 5 of the Health Care PRICE Transparency Act 2.0, (S. 3548) requiring price transparency of services provided in ambulatory surgery centers. Ask the Department of Health and Humans Services to update the federal FAQ guidance for commercial insurers regulated by the Affordable Care Act to treat surveillance colonoscopy as part of the screening continuum without cost-sharing. No specific legislation Support the Gold Card Act (H.R. 4968)
Colorectal Cancer Payment Fairness Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans. No specific legislation 1st Quarter 2024 Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation Support the Colorectal Cancer Payment Fairness Act (H.R. 3382) to accelerate the timeline for removal of cost sharing among Medicare beneficiaries when a preventive screening colonoscopy involves the removal of polyps.
ARC Act of 2023
Client: ASSOCIATION OF BLACK CARDIOLOGISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support coverage of Self Measured Blood Pressure Devices as Durable Medical Equipment under Medicare. No specific legislation. Support coverage of peripheral artery disease screening without patient cost-sharing (H.R. 4261)
ARC Act of 2023
Client: ASSOCIATION OF BLACK CARDIOLOGISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support Amputation Reduction and Compassion Act and revisions to language for reintroduction. Legislation would require screening of Medicare and Medicaid patients who are at risk for non-traumatic limb amputation due to peripheral artery disease. (H.R. 4261) Support the "Treat and Reduce Obesity Act" S. 2407 / H.R. 4818
Treat and Reduce Obesity Act of 2023
Client: ASSOCIATION OF BLACK CARDIOLOGISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support Amputation Reduction and Compassion Act and revisions to language for reintroduction. Legislation would require screening of Medicare and Medicaid patients who are at risk for non-traumatic limb amputation due to peripheral artery disease. (H.R. 4261) Support the "Treat and Reduce Obesity Act" S. 2407 / H.R. 4818
GOLD CARD Act of 2023
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Express concern with Sec. 104 (Ambulatory Surgical Center Price Transparency) of H.R. 5378 of the Lower Costs, More Transparency Act" and oppose Section 5 of the Health Care PRICE Transparency Act 2.0, (S. 3548) requiring price transparency of services provided in ambulatory surgery centers. Ask the Department of Health and Humans Services to update the federal FAQ guidance for commercial insurers regulated by the Affordable Care Act to treat surveillance colonoscopy as part of the screening continuum without cost-sharing. No specific legislation Support the Gold Card Act (H.R. 4968)
Value in Health Care Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 4rd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support generally mitigating or stopping impending cut to the Medicare physician fee schedule conversion factor for CY2025. Support the Improving Seniors Timely Access to Care Act (H.R. 8702/S. 4532)
Value in Health Care Act of 2023
Client: AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 3rd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support generally mitigating or stopping impending cut to the Medicare physician fee schedule conversion factor for CY2025.
Lower Costs, More Transparency Act
Client: AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY · Firm: SUMMIT HEALTH CARE CONSULTING
Express concerns with Sec 103 (Imaging Price Transparency) of H. R. 5378, Lower Costs, More Transparency Act" and Sec. 4 of the Health Care PRICE Transparency Act 2.0 (S. 3548) which would require transparency of imaging services.
Lower Costs, More Transparency Act
Client: AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Express concern with Sec. 104 (Ambulatory Surgical Center Price Transparency) of H.R. 5378 of the Lower Costs, More Transparency Act" and oppose Section 5 of the Health Care PRICE Transparency Act 2.0, (S. 3548) requiring price transparency of services provided in ambulatory surgery centers. Ask the Department of Health and Humans Services to update the federal FAQ guidance for commercial insurers regulated by the Affordable Care Act to treat surveillance colonoscopy as part of the screening continuum without cost-sharing. No specific legislation Support the Gold Card Act (H.R. 4968)
Charles Rochester Blood Clot Prevention and Treatment Act
Client: ASSOCIATION OF BLACK CARDIOLOGISTS · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Charles Rochester Blood Clot Prevention and Treatment Act (H.R. 5699) to raise awareness of deep venous thromboembolism, as well as approaches to improved screening, detection, and diagnosis of DVT and pulmonary embolism. Support the Womens Heart Health Expansion Act of 2024 (HR 7482) which expands the WISEWOMAN program at the Centers for Disease Control and Prevention.
2026 · second_quarter · RR
Parenteral nutrition Breast reconstruction surgery
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2026 · second_quarter · Q2
Oppose the Patients Deserve Price Tags Act (S. 2355 / H.R. 5582). The bill requires price transparency, including discounted cash price and payer-specific negotiated rates, from all imaging providers, including physician practices. Support the he H-1Bs for Physicians and the Healthcare Workforce Act (H.R. 7961), which would exempt healthcare professionals from the $100,000 H-1B petition fee
Support Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule Support the Provider Reimbursement Stability Act (H.R. 8163), which would reform outdated physician fee schedule budget-neutrality requirements, including raising the existing $20 million budget-neutrality trigger to $54.3 million. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would pause the new Medicare -2.5% efficiency adjustment and require CMS to issue a report with data justifying a one-time efficiency adjustment application and only if certain conditions are met. Oppose the Radiology Outpatient Ordering Transmission (ROOT) Act (S. 1692 / H.R. 5737) which requires the consultation of appropriate use criteria for advanced diagnostic imaging in the Medicare program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2026 · second_quarter · Q2
Support reform of the Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule (no specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes Support the Ensuring Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026 which reforms prior authorization processes and applies to Part D, CHIP, Medicaid. No specific legislation introduced in second quarter.
Oppose the Patients Deserve Price Tags Act (S. 2355), specifically Section 5. Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2026 · second_quarter · Q2
Support the Ensuring Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026 which requires prior authorization reform and applies to Part D, CHIP, Medicaid. No bill introduced in 2nd quarter
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2026 · second_quarter · 2T
Support the Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026. Applies prior auth reforms to Part D, CHIP, Medicaid. Not introduced in the 2nd Quarter Support the Fair Access in Residency (FAIR) Act (H.R. 2314 and S. 2715) to require equal recognition of the Comprehensive Osteopathic Medical Licensing Exam (COMLEX) Support the Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816)
Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192), which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via SUMMIT HEALTH CARE CONSULTING
2026 · first_quarter · Q1
Support the Community TEAMS Act (H.R. 3885 / S. 3989) Support Dillon's Law (H.R. 4564)
Support the Resident Physician Shortage Reduction Act (H.R. 4731 / S. 2439)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2026 · first_quarter · Q1
Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Support the Resident Physician Shortage Reduction Act (H.R. 4731 / S. 2439)
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885 / S. 3989)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2026 · first_quarter · Q1
Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2026 · first_quarter · Q1
Oppose the Patients Deserve Price Tags Act (S. 2355), specifically Section 5.
Oppose Centers for Medicare and Medicaid Services' (CMS) proposal to implement an efficiency adjustment to Medicare Physician Fee Schedule payments. Support the Efficiency Adjustment Delay Act (H.R. 7520), which would stop the application of an efficiency adjustment until at least January 1, 2030. Oppose the CMS practice expense site differential proposal (no specific legislation) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2026 · first_quarter · Q1
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Pediatric indications for biologic products to treat inflammatory bowel disease
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS via SUMMIT HEALTH CARE CONSULTING
2026 · first_quarter · RR
Medicare physician payment, physician workforce, prior authorization, access to care, health insurance reform
Medicare physician payment, physician workforce, prior authorization, access to care, health insurance reform
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2025 · fourth_quarter · Q4
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Support exception for H-1B physicians from the Proclamation, Restriction on Entry of Certain Nonimmigrant Workers, as issued by President Trump on Sept. 19, 2025.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2025 · fourth_quarter · Q4
Oppose Centers for Medicare and Medicaid Services' (CMS) proposal to implement an efficiency adjustment to Medicare Physician Fee Schedule payments, as well as oppose the CMS practice expense site differential proposal Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2025 · fourth_quarter · Q4
Medicare physician payment -2.5% efficiency adjustment
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314) to facilitate training of osteopathic medical students Support the Community Training, Education, and Access for Medical Students Act (H.R. 3885)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2025 · fourth_quarter · Q4
Medicare physician payment -2.5% efficiency adjustment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2025 · third_quarter · Q3
Support the Fair Access in Residency (FAIR) Act (S. 2715 / H.R. 2314)
Support the Fair Access in Residency (FAIR) Act (H.R. 2314) to facilitate training of osteopathic medical students
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2025 · third_quarter · Q3
Oppose Centers for Medicare and Medicaid Services' (CMS) proposal to implement an efficiency adjustment to Medicare Physician Fee Schedule payments, as well as oppose the CMS practice expense site differential proposal Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2025 · third_quarter · Q3
Support the Medical Foods and Formulas Access Act (H.R. 5684) Support the Cure Hepatitis C Act (S. 1941) Support Colorados Medicaid State Plan Amendment to allow dispensing fees for the preparation and dispensing of parenteral nutrition as approved by the Colorado General Assembly and signed into law [SB 25-084].
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2025 · second_quarter · Q2
Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514)
Support the Fair Access in Residency (FAIR) Act (H.R. 2314) to facilitate training of osteopathic medical students
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2025 · second_quarter · Q2
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879) Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Oppose S.1692 - Radiology Outpatient Ordering Transmission (ROOT) Act which would re-establish the Medicare Appropriate Use Criteria program for advanced diagnostic imaging
Price transparency for imaging providers (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2025 · second_quarter · Q2
Access to medically necessary foods and formulas for those with gastrointestinal and metabolic disorders (no specific legislation) Oppose policies to the Children's Health Insurance Program and Medicaid that would lead to loss of coverage and access to care (H.R. 1)
Fiscal Year 2026 funding for the National Institutes of Health (no specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2025 · second_quarter · Q2
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Price transparency for ambulatory surgery centers (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2025 · first_quarter · Q1
Prevent cut to Medicare physician payments, Medicare Patient Access and Practice Stabilization Act of 2025 (HR 879)
Oppose cap on indirect cost rates for National Institutes of Health grants (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2025 · first_quarter · Q1
Access to medically necessary foods and formulas for those with gastrointestinal and metabolic disorders.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2025 · first_quarter · Q1
Prevent cut to Medicare physician payment, Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879)
Price transparency for imaging providers (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2025 · first_quarter · Q1
Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 Impose restrictions on prior authorization practices used by Medicare Advantage plans (No specific legislation) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Price transparency for ambulatory surgery centers (No specific legislation) Cap on indirect cost rates for the National Institutes of Health (No specific legislation)
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2024 · fourth_quarter · Q4
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products. Oppose Biosimilar Red Tape Elimination Act (S. 2305) Improve pediatric indications for biologics (no specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2024 · fourth_quarter · Q4
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans (H.R. 8702 / S. 4518) Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation Improving patient access to biosimilars by closing the gap between the reimbursement rates and physician practice acquisition costs (no specific legislation)
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2024 · fourth_quarter · Q4
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 4rd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support generally mitigating or stopping impending cut to the Medicare physician fee schedule conversion factor for CY2025. Support the Improving Seniors Timely Access to Care Act (H.R. 8702/S. 4532)
Support the Safe Step Act to provide protections against step therapy protocols (S. 652, H.R. 2630)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2024 · fourth_quarter · Q4
Support the Strengthening Medicare for Patients and Providers Act, (H.R. 2474), which provides a permanent annual update equal to the increase in the MEI, and the Provider Reimbursement Stability Act (H.R. 6371), which would reform budget neutrality requirements. Generally support elimination or reduction in scheduled Medicare physician fee schedule conversion factor for CY205. Support repeal of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. No specific legislation Support the the Improving Seniors Timely Access to Care Act (H.R. 8702/S. 4532)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2024 · fourth_quarter · 4T
Support for a resolution and proclamation designating November as Stomach Cancer Awareness Month (Senate Resolution 908)
Support Section 748 of the Senate Fiscal Year (FY) 2025 National Defense Authorization Act (NDAA) that calls for a report on a plan for Helicobacter Pylori (H. pylori) testing for certain members of the Armed Forces. (S. 4638)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2024 · third_quarter · Q3
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 3rd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support generally mitigating or stopping impending cut to the Medicare physician fee schedule conversion factor for CY2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2024 · third_quarter · Q3
Support the Strengthening Medicare for Patients and Providers Act, (H.R. 2474), which provides a permanent annual update equal to the increase in the MEI, and the Provider Reimbursement Stability Act (H.R. 6371), which would reform budget neutrality requirements. Generally support elimination or reduction in scheduled Medicare physician fee schedule conversion factor for CY205. Support repeal of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. No specific legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2024 · third_quarter · Q3
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2024 · third_quarter · Q3
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630)
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans (H.R. 8702 / S. 4518) Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2024 · third_quarter · Q3
Inclusion in FY2025 report language to accompany the Department of Defense spending bill requesting the inclusion of stomach cancer in the Peer Reviewed Cancer Research Program. (S. 4921, HR 8774)
Advocate in support for Appropriations bill report language and legislative language in support of a pilot program within the Department of Defense for an h. pylori screening program for military service men and women. S. 4638, H.R. 8070) Support the Stomach Cancer Prevention and Early Detection Act H.R. 9304
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2024 · third_quarter · 3T
Support coverage of Self Measured Blood Pressure Devices as Durable Medical Equipment under Medicare. No specific legislation. Support coverage of peripheral artery disease screening without patient cost-sharing (H.R. 4261)
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2024 · second_quarter · Q2
Enacting an annual, permanent inflationary payment update for Medicare physician payment that is tied to the Medicare Economic Index (MEI) (H.R. 2474); Budget Neutrality reforms (H.R. 6371); Overhaul of MACRAs Merit-based Incentive Payment System (No specific legislation 2nd Q 2024). Modifications to Alternative Payment Models (APM) (S. 3503/H.R. 5013). Support the Rural Physician Workforce Preservation Act (H.R. 8235) to ensure that geographically rural hospitals receive the GME funding prioritization according to Section 126 of the Consolidated Appropriations Act of 2021.
Support the Community Training, Education, and Access for Medical Students Act (Community TEAMS Act) (H.R. 7528 / S. 3968). Support the Fair Access In Residency Act (H.R. 751) which would provide transparency by reporting annually on the number of DO and MD applicants and accepted residents; and affirm that DO applications and the COMLEX-USA are accepted for consideration. Support the Rural Physician Workforce Production Act (H.R. 834/S.230) which would increase the physician workforce in rural areas by improving Medicare reimbursement for rural residency training. Support a five-year reauthorization at $300 million per year to provide sustainable funding for existing Teaching Health Center programs and support the development of new programs.
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2024 · second_quarter · Q2
Support legislation to ban the sale of water beads, Ban Water Beads Act (H.R. 6486); Esther's Law (S. 4298)
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2024 · second_quarter · Q2
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630)
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans (H.R. 8702 / S. 4518) Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2024 · second_quarter · Q2
Support the Strengthening Medicare for Patients and Providers Act, (H.R. 2474), which provides a permanent annual update equal to the increase in the MEI, and the Provider Reimbursement Stability Act (H.R. 6371), which would make much-needed reforms to budget neutrality. ASNC requests that passage of both bills be considered a priority. Support repeal of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. No specific legislation
Filing targets: SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2024 · second_quarter · Q2
Inclusion in FY2025 report language to accompany the Department of Defense spending bill requesting the inclusion of stomach cancer in the Peer Reviewed Cancer Research Program. No specific bill for 1st Quarter 2024
Advocate in support for Appropriations bill report language and legislative language in support of a pilot program within the Department of Defense for an h. pylori screening program for military service men and women. No specific legislation 2st Quarter 2024.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2024 · second_quarter · Q2
Support coverage of Self Measured Blood Pressure Devices as Durable Medical Equipment under Medicare. No specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2024 · first_quarter · Q1
Support Amputation Reduction and Compassion Act and revisions to language for reintroduction. Legislation would require screening of Medicare and Medicaid patients who are at risk for non-traumatic limb amputation due to peripheral artery disease. (H.R. 4261) Support the "Treat and Reduce Obesity Act" S. 2407 / H.R. 4818
Support the Charles Rochester Blood Clot Prevention and Treatment Act (H.R. 5699) to raise awareness of deep venous thromboembolism, as well as approaches to improved screening, detection, and diagnosis of DVT and pulmonary embolism. Support the Womens Heart Health Expansion Act of 2024 (HR 7482) which expands the WISEWOMAN program at the Centers for Disease Control and Prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2024 · first_quarter · Q1
Support the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683) to eliminate the Medicare cut to physician payments.
Support the Community Training, Education, and Access for Medical Students Act (Community TEAMS Act) (H.R. 7528)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2024 · first_quarter · Q1
Support to Codify and enhance CMS regulations that advance interoperability and improve prior authorization in Medicare Advantage plans. No specific legislation 1st Quarter 2024 Support (H.R. 2474) that would provide Medicare payments for physician services with an annual inflationary update based on the Medicare Economic Index, similar to updates received by other health care providers. Revise budget neutrality requirements and triggers by supporting and passing the Provider Reimbursement Stability Act (H.R. 6371). Reduce administrative and financial burden of participation in the Merit-based Incentive Payment System. No specific legislation Support the Colorectal Cancer Payment Fairness Act (H.R. 3382) to accelerate the timeline for removal of cost sharing among Medicare beneficiaries when a preventive screening colonoscopy involves the removal of polyps.
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Express concern with Sec. 104 (Ambulatory Surgical Center Price Transparency) of H.R. 5378 of the Lower Costs, More Transparency Act" and oppose Section 5 of the Health Care PRICE Transparency Act 2.0, (S. 3548) requiring price transparency of services provided in ambulatory surgery centers. Ask the Department of Health and Humans Services to update the federal FAQ guidance for commercial insurers regulated by the Affordable Care Act to treat surveillance colonoscopy as part of the screening continuum without cost-sharing. No specific legislation Support the Gold Card Act (H.R. 4968)
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2024 · first_quarter · Q1
Express concerns with Sec 103 (Imaging Price Transparency) of H. R. 5378, Lower Costs, More Transparency Act" and Sec. 4 of the Health Care PRICE Transparency Act 2.0 (S. 3548) which would require transparency of imaging services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2024 · first_quarter · Q1
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Support legislation to ban the sale of water beads, Ban Water Beads Act (H.R. 6486); no specific legislation 1st Quarter 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2024 · first_quarter · Q1
Advocate in support for Appropriations bill report language and legislative language in support of a pilot program within the Department of Defense for an h. pylori screening program for military service men and women. No specific legislation 1st Quarter 2024.
Inclusion in FY2025 report language to accompany the Department of Defense spending bill requesting the inclusion of stomach cancer in the Peer Reviewed Cancer Research Program. No specific bill for 1st Quarter 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2023 · fourth_quarter · Q4
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Support the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683) to eliminate the Medicare cut to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2023 · fourth_quarter · Q4
Support Amputation Reduction and Compassion Act and revisions to language for reintroduction. Legislation would require screening of Medicare and Medicaid patients who are at risk for non-traumatic limb amputation due to peripheral artery disease. (H.R. 4261) Support the "Treat and Reduce Obesity Act" S. 2407 / H.R. 4818
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2023 · fourth_quarter · Q4
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Support the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683) to eliminate a Medicare cut to physician payments.
Express concerns with Sec 103 (Imaging Price Transparency) of H. R. 5378, Lower Costs, More Transparency Act" and Sec. 4 of the Health Care PRICE Transparency Act 2.0 (S. 3548) which would require transparency of imaging services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2023 · fourth_quarter · Q4
Inclusion in FY2025 report language to accompany the Department of Defense spending bill requesting the inclusion of stomach cancer in the Peer Reviewed Cancer Research Program.
Support a resolution expressing support for the goals of Stomach Cancer Awareness Month (S. Res. 481)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2023 · fourth_quarter · Q4
Development of legislative language that would set safety standards for high-power, small magnets and concerns about ingestion of water beads. (No specific legislation) Support legislation to ban the sale of water beads, Ban Water Beads Act (H.R. 6486)
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2023 · fourth_quarter · Q4
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Support for eliminating the Medicare payment cuts to physicians, Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683)
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Express concern with Sec. 104 (Ambulatory Surgical Center Price Transparency) of H.R. 5378 of the Lower Costs, More Transparency Act" and oppose Section 5 of the Health Care PRICE Transparency Act 2.0, (S. 3548) requiring price transparency of services provided in ambulatory surgery centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2023 · third_quarter · Q3
Support Amputation Reduction and Compassion Act and revisions to language for reintroduction. Legislation would require screening of Medicare and Medicaid patients who are at risk for non-traumatic limb amputation due to peripheral artery disease. (H.R. 4261) Support the "Treat and Reduce Obesity Act" S. 2407 / H.R. 4818
Support National CholesterolEducation Month, H.Res. 709
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2023 · third_quarter · Q3
Support the Safe Step Act which provides exceptions to step therapy protocols used by insurance plans covered by ERISA plans. (S. 652, H.R. 2630)
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2023 · third_quarter · Q3
Development of legislative language that would set safety standards for high-power, small magnets and concerns about ingestion of water beads. (No specific legislation)
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans. (No specific legislation) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Oppose Section 901 of the "Primary Care and Health Workforce Expansion Act" (HR 2840). Section 901 would remove the distinction between biosimilars and interchangeable biologics which NASPGHAN believes puts children with inflammatory bowel diseases at increased risk of adverse medical events.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2023 · third_quarter · Q3
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472)
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Express concern with Sec. 104 (Ambulatory Surgical Center Price Transparency) of H.R. 5378 of the Lower Costs, More Transparency Act"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2023 · third_quarter · Q3
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Express concerns with Sec 103 (Imaging Price Transparency) of H. R. 5378, Lower Costs, More Transparency Act"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2023 · second_quarter · Q2
Encourage House members join the Black Maternal Health Caucus (no specific legislation) Support for the Access to AEDs Act (H.R. 2370)
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Support Amputation Reduction and Compassion Act and revisions to language for reintroduction. Legislation would require screening of Medicare and Medicaid patients who are at risk for non-traumatic limb amputation due to peripheral artery disease. (H.R. 4261)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2023 · second_quarter · Q2
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472)
Support the Safe Step Act which provides exceptions to step therapy protocols used by insurance plans covered by ERISA plans. (S. 652, H.R. 2630)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2023 · second_quarter · Q2
Development of legislative language that would set safety standards for high-power, small magnets. (No specific legislation)
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans. (No specific legislation) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2023 · second_quarter · Q2
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Advocate for congressional oversight of insurance companies and pharmaceutical benefit management companies regarding utilization management of biologics used in the treatment of inflammatory bowel disease (no specific legislation)
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2023 · second_quarter · Q2
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Support reform of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2023 · second_quarter · Q2
Advocate for increased funding for the National Cancer Institute for FY2024 Advocate that stomach cancer remain included in the Department of Defense's Peer Reviewed Cancer Research Program for FY2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2023 · first_quarter · Q1
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472)
Support the Safe Step Act which provides exceptions to step therapy protocols used by insurance plans covered by ERISA plans. (S. 652, H.R. 2630)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2023 · first_quarter · Q1
Encourage House members join the Black Maternal Health Caucus
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Support Amputation Reduction and Compassion Act and revisions to language for reintroduction. Legislation would require screening of Medicare and Medicaid patients who are at risk for non-traumatic limb amputation due to peripheral artery disease.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2023 · first_quarter · Q1
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472) Support reform of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. (No specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2023 · first_quarter · Q1
Support using the Medicare Economic Index (MEI) for updating Medicare physician payments (H.R. 2472)
Support the Safe Step Act which provides exceptions to step therapy protocols used by health plans for consumers covered under ERISA (S 652, HR 2630) Advocate for congressional oversight of insurance companies and pharmaceutical benefit management companies regarding utilization management of biologics used in the treatment of inflammatory bowel disease
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2023 · first_quarter · Q1
Advocate for increased funding for the National Cancer Institute for FY2024 Advocate that stomach cancer remain included in the Department of Defense's Peer Reviewed Cancer Research Program for FY2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2023 · first_quarter · Q1
Support increased appropriations for FY2024 for the Pediatric Subspecialty Loan Repayment Program
Development of legislative language that would set safety standards for high-power, small magnets. (No specific legislation)
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans. (No specific legislation) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Submission of testimony to the House Committee on Oversight and Accountability Subcommittee on Health Care and Financial Services pertaining to the prevention of future formula shortages. (No specific legislation)
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2022 · fourth_quarter · Q4
Support for the Amputation Reduction and Compassion (ARC) Act of 2021 (HR 2631)
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2022 · fourth_quarter · Q4
Support the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act (S. 2076 / H.R. 3932)
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2022 · fourth_quarter · Q4
Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2022 · fourth_quarter · Q4
Support repeal of Sec.1834(q)(4)(A) of the Social Security Act(42 U.S.C. 1395m) established by the Protecting Access to Medicare Act (PAMA) [Public Law 113-93], establishing the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. No specific legislation. Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2022 · fourth_quarter · Q4
Medical Nutrition Equity Act (S. 2013 / H.R. 3783), which would require Medicare, Medicaid, FEHBP, CHIP and commercial payers to cover medically necessary nutrition for gastrointestinal disorders and metabolic disorders.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2022 · fourth_quarter · Q4
Support for a resolution to designate November as Stomach Cancer Awareness Month. S.Res 839
Filing targets: SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2022 · third_quarter · Q3
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800. Support amendment to Inflation Reduction Act (HR 5376) by Sen. John Barrasso (R-WY) to amend a drug pricing provision (Subtitle B-Prescription Drug Pricing Reform) in the bill to require drug manufacturers directly refund the government excess costs above the maximum fair price for certain Part B drugs subject to price negotiation. The amendment would have effectively exempted any pricing concessions from the Average Sales Price so provider payment rates are not artificially reduced. The amendment was not considered.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS via SUMMIT HEALTH CARE CONSULTING
2022 · third_quarter · RR
Medicare Physician Payment and Value Based Care Physician Workforce Health Prevention Access to Care and Treatment Prior Authorization and Step Therapy
Medicare Physician Payment and Value Based Care Physician Workforce Health Prevention Access to Care and Treatment Prior Authorization and Step Therapy
Medicare Physician Payment and Value Based Care Physician Workforce Health Prevention Access to Care and Treatment Prior Authorization and Step Therapy
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2022 · third_quarter · Q3
Support the following provisions of the Inflation Reduction Act (HR 5376) Subtitle C-Affordable Care Act Subsidies SEC. 12001. IMPROVE AFFORDABILITY AND REDUCE PREMIUM COSTS OF HEALTH INSURANCE FOR CONSUMERS. PART 3-PART D IMPROVEMENTS AND MAXIMUM OUT-OF-POCKET CAP FOR MEDICARE BENEFICIARIES SEC. 11201. MEDICARE PART D BENEFIT REDESIGN.
Filing targets: SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2022 · third_quarter · Q3
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800. Support amendment to Inflation Reduction Act (HR 5376) by Sen. John Barrasso (R-WY) to amend a drug pricing provision (Subtitle B-Prescription Drug Pricing Reform) in the bill to require drug manufacturers directly refund the government excess costs above the maximum fair price for certain Part B drugs subject to price negotiation. The amendment would have effectively exempted any pricing concessions from the Average Sales Price so provider payment rates are not artificially reduced. The amendment was not considered.
Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2022 · third_quarter · Q3
Medical Nutrition Equity Act (S. 2013 / H.R. 3783), which would require Medicare, Medicaid, FEHBP, CHIP and commercial payers to cover medically necessary nutrition for gastrointestinal disorders and metabolic disorders. Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2022 · third_quarter · Q3
Support repeal of Sec.1834(q)(4)(A) of the Social Security Act(42 U.S.C. 1395m) established by the Protecting Access to Medicare Act (PAMA) [Public Law 113-93], establishing the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. No specific legislation. Also support language in the report accompanying the FY2022 Labor-Health and Human Services-Education spending bill that would require the Centers for Medicare and Medicaid Services to report to Congress on the status of implementation of the AUC Program. Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2022 · third_quarter · Q3
Support for report language to accompany the FY2024 Department of Defense Spending Bill to include stomach cancer in the Department of Defense's Peer Reviewed Cancer Research Program
Support for a resolution to designate November as Stomach Cancer Awareness Month
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2022 · second_quarter · Q2
Support the Affordable Insulin Now Act (S. 3700) which would cap patient out-of-pocket costs for insulin
Filing targets: SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2022 · second_quarter · Q2
Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2022 · second_quarter · Q2
Support Fiscal Year 2023 funding of at least $30 million for the Pediatric Subspecialty Loan Repayment Program. Implementation of Pediatric Subspecialty Loan Repayment Program
Support Magnet Injury Prevention Act (S. 4479 and H.R. 8199) which designates certain high-powered magnets as banned hazardous products if they meet certain criteria
Medical Nutrition Equity Act (S. 2013 / H.R. 3783), which would require Medicare, Medicaid, FEHBP, CHIP and commercial payers to cover medically necessary nutrition for gastrointestinal disorders and metabolic disorders. Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2022 · second_quarter · Q2
Support repeal of Sec.1834(q)(4)(A) of the Social Security Act(42 U.S.C. 1395m) established by the Protecting Access to Medicare Act (PAMA) [Public Law 113-93], establishing the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. No specific legislation. Also support language in the report accompanying the FY2022 Labor-Health and Human Services-Education spending bill that would require the Centers for Medicare and Medicaid Services to report to Congress on the status of implementation of the AUC Program. Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2022 · second_quarter · Q2
Inclusion of stomach cancer as eligible for research funding under the Department of Defense's Peer Reviewed Cancer Research Program for Fiscal Year 2023 Increased funding for the National Cancer Institute for FY 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2022 · first_quarter · Q1
Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider. Support the Black Maternal Health Momnibus Act of 2021 which comprehensively addresses every dimension of the maternal health crisis in America (HR 959 / S 346) Endorse the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act (H.R.6584) ABC sign-on support of letter to Congressional leaders urging they address the use of synthetic nicotine in e-cigarettes.
Oppose clinical labor cuts finalized with the CY 2022 Physician Fee Schedule. No specific legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2022 · first_quarter · Q1
Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program.
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2022 · first_quarter · Q1
Support Magnet Injury Prevention Act which would ban the sale of high-powered magnet sets. No specific legislation in first quarter of 2022.
Medical Nutrition Equity Act (S. 2013 / H.R. 3783), which would require Medicare, Medicaid, FEHBP, CHIP and commercial payers to cover medically necessary nutrition for gastrointestinal disorders and metabolic disorders. Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider. March meeting with the Food and Drug Administration to discuss challenges with access to Ethanol for use in locks to prevent central line infections in pediatric patients with intestinal failure. Outreach to the Food and Drug Administration regarding Drug development and drug approval in eosinophilic esophagitis.
AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY via SUMMIT HEALTH CARE CONSULTING
2022 · first_quarter · Q1
Support repeal of Sec.1834(q)(4)(A) of the Social Security Act(42 U.S.C. 1395m) established by the Protecting Access to Medicare Act (PAMA) [Public Law 113-93], establishing the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. No specific legislation. Also support language in the report accompanying the FY2022 Labor-Health and Human Services-Education spending bill that would require the Centers for Medicare and Medicaid Services to report to Congress on the status of implementation of the AUC Program. Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2022 · first_quarter · Q1
Inclusion of stomach cancer as eligible for research funding under the Department of Defense's Peer Reviewed Cancer Research Program for Fiscal Year 2023 Increased funding for the National Cancer Institute for FY 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY via SUMMIT HEALTH CARE CONSULTING
2021 · fourth_quarter · Q4
Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.
Support extension of 3.75% Medicare physician fee schedule payment adjustment through CY 2022 (no specific legislation). Support congressional action to prevent the 4% Medicare sequester for CY2022 as a result of the American Rescue Plan (no specific legislation). Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF BLACK CARDIOLOGISTS via SUMMIT HEALTH CARE CONSULTING
2021 · fourth_quarter · Q4
Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider. Support the Black Maternal Health Momnibus Act of 2021 which comprehensively addresses every dimension of the maternal health crisis in America (HR 959 / S 346) Supportive comments on the draft Diverse and Equitable Participation in Clinical Trials (DEPICT) Act (H.R.6584)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEBBIES DREAM FOUNDATION CURING STOMACH CANCER via SUMMIT HEALTH CARE CONSULTING
2021 · fourth_quarter · Q4
Inclusion of stomach cancer as eligible for research funding under the Department of Defense's Peer Reviewed Cancer Research Program for Fiscal Year 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION via SUMMIT HEALTH CARE CONSULTING
2021 · fourth_quarter · Q4
Support Fiscal Year 2022 funding of at least $50 million for the Pediatric Subspecialty Loan Repayment Program (S. 3062 / H.R. 4502)
Medical Nutrition Equity Act (S. 2013 / H.R. 3783), which would require Medicare, Medicaid, FEHBP, CHIP and commercial payers to cover medically necessary nutrition for gastrointestinal disorders and metabolic disorders. Support the Safe Step Act (S. 464 / H.R. 2163) which creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider. Request meeting with the Food and Drug Administration to discuss challenges with access to Ethanol for use in locks to prevent central line infections in pediatric patients with intestinal failure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support the Protect Infants from Formula Shortages Act (S. 4256) to prevent future shortages of infant formula by requiring manufacturers to report to the FDA any anticipated supply or productions disruptions.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Support $50 million for the Centers for Disease Control and Prevention's Colorectal Cancer Control Program for Fiscal Year 2023. No specific legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support Fiscal Year 2022 funding of at least $50 million for the Pediatric Subspecialty Loan Repayment Program (S. 3062 / H.R. 4502)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Support Magnet Injury Prevention Act which would ban the sale of high-powered magnet sets. No specific legislation in fourth quarter of 2021.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE